FLASH irradiations use dose-rates orders of magnitude higher than commonly used in
patient treatments. Such irradiations have shown interesting normal tissue sparing in cell …

Abstract 155 Tb [t 1/2= 5.32 d, E γ= 87 keV (32%); 105 keV (25%)(IAEA, 2021) is a novel
promising radionuclide for theranostic applications in nuclear medicine. Its physical …

The availability of novel radionuclides plays a fundamental role in the development of
personalized nuclear medicine. In particular, there is growing interest in pairs formed by two …

Abstract 43 Sc and 44 Sc are positron emitter radionuclides that, in conjunction with the β−
emitter 47 Sc, represent one of the most promising possibilities for theranostics in nuclear …

Abstract The Clatterbridge Cancer Centre (CCC) in the United Kingdom is the world's first
hospital proton beam therapy facility, providing treatment for ocular cancers since 1989. A …

Novel medical radioisotopes for both diagnostic and therapy are essential for the future
development of personalized nuclear medicine. Among them, radiometals can be used to …

Radiometals play a fundamental role in the development of personalized nuclear medicine.
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …

The availability of novel medical radionuclides is a key point in the development of
personalised nuclear medicine. In particular, copper radioisotopes are attracting …

The future development of personalized nuclear medicine relies on the availability of novel
medical radionuclides. In particular, radiometals are attracting considerable interest since …

The characterization of particle accelerator induced neutron fields is challenging but
fundamental for research and industrial activities, including radiation protection, neutron …